JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma

<p><em>JCO</em> Editorial Fellow Peter Li and <em>JCO</em> Associate Editor Eileen O'Reilly discuss the ASCO 25 Simultaneous Publication paper "<a href= "https://ascopubs.org/doi/10.1200/JCO-25-00746" target="_blank" rel="noopener">Tumor-Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal, Phase 3 PANOVA-3 Study</a>."</p> <h2>Transcript</h2> <p class="MsoNormal" style= "text-align: center; margin: 12.0pt 0in 12.0pt 0in;" align= "center"><span style= "font-family: arial, helvetica, sans-serif;"><em style= "mso-bidi-font-style: normal;"><span lang="EN" xml:lang="EN">The guest on this podcast episode has no disclosures to declare.</span></em></span></p> <p class="MsoNormal" style="margin: 12.0pt 0in 12.0pt 0in;"> <span style= "font-family: arial, helvetica, sans-serif;"><strong style= "mso-bidi-font-weight: normal;"><span lang="EN" xml:lang="EN">Dr. Peter Li:</span></strong> <span lang="EN" xml:lang="EN">Hello...